Impact of vasopressin analogues on the gut mucosal microcirculation

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 2, 2008, Pages 351-358

  Asfar, Pierre ^a,b   Bracht, Hendrik ^c   Radermacher, Peter ^c  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung   (Germany)

Author keywords

clinical studies; experimental; haemodynamics; microcirculation; septic shock; splanchnic circulation; terlipressin; vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; HORMONE RECEPTOR AFFECTING AGENT; NORADRENALIN; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR AGONIST;

CLINICAL STUDY; CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXPERIMENTAL STUDY; HEMODYNAMICS; HUMAN; INTESTINE MUCOSA; ISCHEMIA; METABOLISM; MICROCIRCULATION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW;

ANIMALS; HUMANS; INTESTINAL MUCOSA; MICROCIRCULATION; RECEPTORS, VASOPRESSIN; SPLANCHNIC CIRCULATION; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 44949199073     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.02.009     Document Type: Review

References (30)

1. Landry D.W., and Oliver J.A. The pathogenesis of vasodilatory shock. The New England Journal of Medicine 345 (2001) 588-595
2. Hassoun H.T., Kone B.C., Mercer D.W., et al. Post-injury multiple organ failure: the role of the gut. Shock 15 (2001) 1-10
3. Reilly P.M., Wilkins K.B., Fuh K.C., et al. The mesenteric haemodynamic response to circulatory shock: an overview. Shock 15 (2001) 329-343
4. Schmid P.G., Abboud F.M., Wendling M.G., et al. Regional vascular effects of vasopressin: plasma levels and circulatory responses. American Journal of Physiology 227 (1974) 998-1004
5. Garcia-Villalon A.L., Garcia J.L., Fernandez N., et al. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. British Journal of Pharmacology 118 (1996) 1848-1854
6. Laszlo F., Karacsony G., Pavo I., et al. Aggressive role of vasopressin in development of different gastric lesions in rats. European Journal of Pharmacology 258 (1994) 15-22
7. Laszlo F., and Whittle B.J. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia. European Journal of Pharmacology 260 (1994) 265-268
8. Asfar P., Pierrot M., Veal N., et al. Low-dose terlipressin improves systemic and splanchnic haemodynamics in fluid-challenged endotoxic rats. Critical Care Medicine 31 (2003) 215-220
9. Martikainen T.J., Tenhunen J.J., Uusaro A., and Ruokonen E. The effects of vasopressin on systemic and splanchnic haemodynamics and metabolism in endotoxin shock. Anesthesia and Analgesia 97 (2003) 1756-1763
10. Guzman J.A., Rosado A.E., and Kruse J.A. Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic haemodynamic and oxygen transport effects. Journal of Applied Physiology 95 (2003) 803-809
11. Hiltebrand L.B., Krejci V., Jakob S.M., et al. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 106 (2007) 1156-1167
12. Sun Q., Dimopoulos G., Nguyen D.N., et al. Low-dose vasopressin in the treatment of septic shock in sheep. American Journal of Respiratory and Critical Care Medicine 168 (2003) 481-486 Epub 2003 Jun 5
13. Asfar P., Hauser B., Ivanyi Z., et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Critical Care Medicine 33 (2005) 373-380
14. Martikainen T.J., Uusaro A., Tenhunen J.J., and Ruokonen E. Dobutamine compensates deleterious haemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock. Acta Anaesthesiologica Scandinavica 48 (2004) 935-943
15. Malay M.B., Ashton J.L., Dahl K., et al. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Critical Care Medicine 32 (2004) 1327-1331
16. Bennett T., Mahajan R.P., March J.E., et al. Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. British Journal of Anaesthesia 93 (2004) 400-407
17. Westphal M., Freise H., Kehrel B.E., et al. Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Critical Care Medicine 32 (2004) 194-200
18. Knotzer H., Maier S., Dunser M.W., et al. Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model. Intensive Care Medicine 32 (2006) 170-174
19. Knotzer H., Pajk W., Maier S., et al. Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. American Journal of Physiology. Heart and Circulatory Physiology 289 (2005) H168-H173
20. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
21. Malay M.B., Ashton Jr. R.C., Landry D.W., and Townsend R.N. Low-dose vasopressin in the treatment of vasodilatory septic shock. The Journal of Trauma 47 (1999) 699-703
22. Holmes C.L., Walley K.R., Chittock D.R., et al. The effects of vasopressin on haemodynamics and renal function in severe septic shock: a case series. Intensive Care Medicine 27 (2001) 1416-1421
23. Patel B.M., Chittock D.R., Russell J.A., and Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582
24. O'Brien A., Clapp L., and Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 359 (2002) 1209-1210
25. Dunser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319 Epub 2003 May 5
26. Leone M., Albanese J., Delmas A., et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 22 (2004) 314-319
27. Lauzier F., Levy B., Lamarre P., and Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Medicine 32 (2006) 1782-1789
28. Klinzing S., Simon M., Reinhart K., et al. High-dose vasopressin is not superior to norepinephrine in septic shock. Critical Care Medicine 31 (2003) 2646-2650
29. Creteur J., De Backer D., and Vincent J.L. Does gastric tonometry monitor splanchnic perfusion?. Critical Care Medicine 27 (1999) 2480-2484
30. Morelli A., Rocco M., Conti G., et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Medicine 30 (2004) 597-604